VIDAS® D-dimer: Fast quantitative ELISA for measuring D-dimer in plasma

Clinical Chemistry

Volumn 42, Issue 3, 1996, Pages 410-415

  Pittet, Jean Louis ^a   De Moerloose, Philippe ^b   Reber, Guido ^b   Durand, Catherine ^a   Villard, Cécile ^a   Piga, Nadia ^a   Rolland, Dominique ^a   Comby, Serge ^a   Dupuy, Georges ^a  

^a BIOMÉRIEUX   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

coagulation; fibrin(ogen) degradation products; thromboembolism

Indexed keywords

BILIRUBIN; FIBRINOGEN DEGRADATION PRODUCT; HEMOGLOBIN; HEPARIN; ALKALINE PHOSPHATASE; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; MONOCLONAL ANTIBODY;

ARTICLE; AUTOMATION; BLOOD ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; THROMBOEMBOLISM; ANIMAL; ANTIBODY SPECIFICITY; AUTOANALYSIS; BAGG ALBINO MOUSE; COMPARATIVE STUDY; FEMALE; METHODOLOGY; MOUSE; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALKALINE PHOSPHATASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; AUTOANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MICE; MICE, INBRED BALB C; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0029664592     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.3.410     Document Type: Article

References (23)

1. Pizzo SV, Schwartz ML, Hill RL, McKee PA. The effect of plasmin on the subunit structure of human fibrin. J Biol Chem 1973;248: 4574-83.
2. Francis CW, Marder VJ. A molecular model of plasmic degradation of crosslinked fibrin. Semin Thromb Hemost 1982;8:25-35.
3. Graeff H, Hafter R. Detection and relevance of crosslinked fibrin derivatives in blood. Semin Thromb Hemost 1982;8:57-68.
4. Francis CW, Marder VJ, Martin SE. Plasmic degradation of crosslinked fibrin. Structural analysis of the particulate clot and identification of new macromolecular soluble complexes. Blood 1980;56:456-64.
5. Mosesson MW. Terminology for macromolecular derivatives of crosslinked fibrin. Thromb Haemost 1995;73:725-6.
6. Boucheix C, Mirshahi M, Soria J, Soria C, Perrot JY, Bernadou A, Rosenfeld C. Monoclonal antibodies for domains which are differentially expressed in fibrinogen degradation products or in fibrin degradation products. In: Peeters H, ed. Proceedings of the 30th colloquium: protides of the biological fluids. Oxford, UK: Pergamon Press, 1982:399-402.
7. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, et al. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983;31:767-78.
8. Raimondi P, Bongard O, de Moerloose P, Reber G, Waldvogel F, Bounameaux H. D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res 1993;69: 125-30.
9. Hunt FA, Rylatt DB, Hart RA, Bundesen PG. Serum crosslinked fibrin and fibrinogen/fibrin degradation products in disorders associated with activation of the coagulation of fibrinolytic system. Br J Haematol 1985;60:715-22.
10. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aids in suspected venous thromboembolism. An overview. Thromb Haemost 1994;71:1-6.
11. Van Beek EJR, van den Ende B, Berckmans RJ, van der Heide YT, Brandjes DPM, Sturk A, ten Cate JW. A comparative analysis of D-dimer assays in patients with clinically suspected pulmonary embolism. Thromb Haemost 1993;70:408-13.
12. de Moerloose P, Reber G, Minazio P, Bounameaux H, Durand C, Dupuy G, et al. VIDAS D-DIMER, a new immunoenzymatic assay for fibrin degradation products [Abstract]. Blood 1994;80:695.
13. Köhler G, Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-7.
14. Köhler G, Milstein C. Derivation of specific antibody producing tissue culture and tumor lines by cells fusion. Eur J Immunol 1976;6:511-9.
15. Dudley RA, Edwards P, Ekins RP, Finney DJ, McKenzie IGM, Raab GM, et al. Guidelines for immunoassay data processing. Clin Chem 1985;31:1264-71.
16. Koppert PW, Koopman J, Haverkate F, Nieuwenhuizen W. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B 54-118) in degradation products of fibrin and of fibrinogen. Blood 1986;68: 437-41.
17. Declerck PJ, Mombaerts P, Holvoet P, de Mol M, Collen D. Fibrinolytic response and fibrin fragment D-dimer level in patients with deep vein thrombosis. Thromb Haemost 1987;58:1024-9.
18. Ellis DR, Eaton AS, Plank MC, Butman BT, Ebert RF. A comparative evaluation of ELISA for D-dimer and related fibrin(ogen) degradation products. Blood Coagul Fibrinolysis 1993;4:537-49.
19. Masci PP, Whitaker AN, Winzor DJ. A simple chromatographic procedure for the purification of the D-dimer fragment from crosslinked fibrin. Anal Biochem 1985;147:128-35.
20. Steiner J, Braun P, Byrd P. A comparison of three comparative assays for fibrin degradation products and D-dimer [Abstract]. Thromb Haemost 1993;69:835.
21. Pfitzner A, Dempfle CE, Fahnle M, Heene DL. Immunological assays for fibrin monomer and D-dimer: characterization of analytes detected [Abstract]. Thromb Haemost 1995;73:1228.
22. Pittet JL, Lelouarn J. VIDAS D-DIMER: a new system for the assay of D-dimer in emergency [Abstract]. Thromb Haemost 1995;73: 1101.
23. de Moerloose P, Desmarais S, Bounameaux H, Reber G, Perrier A, Dupuy G, Pittet JL. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism. Thromb Haemost 1996;75:11-3.